High Molecular Weight Impurity Detection with SEC

Size Exclusion Chromatography (SEC), also known as gel filtration chromatography, is a powerful analytical technique used to separate and characterize biomolecules based on their hydrodynamic size in solution. The method employs a porous stationary phase (typically cross-linked polymer beads) that selectively retains smaller molecules within the pores while allowing larger molecules to elute faster. Unlike other chromatographic techniques, SEC does not rely on chemical interactions but rather on molecular size differences, making it ideal for detecting high molecular weight (HMW) impurities such as aggregates, fragments, or conjugated species. Coupled with multi-angle light scattering (MALS), refractive index (RI), or UV detection, SEC provides quantitative and qualitative analysis of HMW impurities in compliance with ICH Q6B, USP <621>, and EP 2.2.30.

Applications in Impurity Test

SEC stands out as the gold standard for HMW impurity analysis due to its non-destructive nature, high resolution, and compatibility with diverse detection methods. SEC requires no denaturing conditions, preserving the native state of proteins and enabling accurate aggregate quantification. The method's broad dynamic range allows simultaneous detection of monomers, small aggregates, and large particulates in a single run. When combined with MALS detection, SEC provides absolute molecular weight measurements without reliance on column calibration standards, eliminating inaccuracies caused by non-ideal elution behavior. Additionally, SEC's low shear forces minimize artificial aggregate formation during analysis, ensuring reliable results. With full compliance with ICH guidelines, SEC offers a robust, reproducible, and regulatory-friendly solution for HMW impurity profiling in biologics and complex therapeutics.

SEC is widely applied in pharmaceutical development and quality control for analyzing:

• Monoclonal antibodies (mAbs) and recombinant proteins to quantify aggregates (dimers, oligomers) and fragments.
• Vaccines and gene therapies (e.g., AAV vectors, mRNA-LNPs) for assessing payload integrity and aggregation.
• Biosimilars and biologics to compare HMW impurity profiles against reference products.
• Peptides and small-molecule conjugates (e.g., antibody-drug conjugates, ADCs) to monitor stability and degradation.
• Polysaccharides and polymer-based drug formulations for molecular weight distribution analysis.

SEC is particularly valuable for stability studies, lot-release testing, and comparability assessments, ensuring product efficacy and safety.

PharmaAnalytica's Technology Platform

PharmaAnalytica's SEC-Based Impurity Test Service

PharmaAnalytica's SEC-based high molecular weight impurity analysis delivers unparalleled precision in biologics characterization through advanced chromatographic separation and detection technologies. Our service integrates sophisticated instrumentation with deep regulatory knowledge to provide comprehensive solutions for your therapeutic development needs.

High-Resolution Separation & Advanced Detection

PharmaAnalytica employs state-of-the-art SEC systems with MALS, RI, and UV detectors to achieve unmatched sensitivity for HMW impurities (detection limits as low as 0.1%). Our optimized columns and buffers ensure baseline separation of monomers, fragments, and aggregates.

Regulatory Compliance & Method Validation

Our protocols adhere to ICH Q6B, USP <621>, and EP 2.2.30 requirements. Each method undergoes rigorous validation (precision, accuracy, linearity, LOQ/LOD) and includes system suitability controls to guarantee data integrity for regulatory submissions.

Customized Solutions for Complex Matrices

We develop tailored SEC methods for challenging samples (e.g., viscous formulations, ADCs, LNPs) using guard columns, orthogonal techniques (AUC, DLS), and stress-testing protocols to mimic real-world conditions.

Accelerated Timelines with Scientific Excellence

PharmaAnalytica's streamlined analytical workflows ensure industry-leading efficiency in delivering high-quality HMW impurity characterization data. Our optimized SEC platforms and experienced scientific team work in tandem to provide priority project execution, seamless method transfer and comprehensive technical support.

From formulation screening to commercial batch release, we support every stage of your product lifecycle with scientifically rigorous, compliance-ready data that drives informed decision-making.